Literature DB >> 27637959

The epidemiology of multiple sclerosis: insights to a causal cascade.

D S Goodin1.   

Abstract

MS-pathogenesis involves both genetic-susceptibility and environmental determinants. Three (or more) sequential environmental-factors are implicated. The first acts near birth, the second acts during childhood/adolescence, and the third acts subsequently. Two candidate factors (vitamin D deficiency and Epstein-Barr viral infection) seem particularly well-suited to the first two environmental-events but other factors (e.g., obesity and smoking behavior) seem also to be involved in the causal scheme. MS-pathogenesis can be modeled by incorporating both the environmental and genetic-factors into a causal scheme, which can then help to explain some of the changes in MS-epidemiology (e.g., increasing disease-prevalence, changing sex-ratio, and regional-variations in monozygotic-twin-concordance-rates), which have been taking place recently. This model suggests that genetic-susceptibility is overwhelmingly the most important determinant of MS and that, at least, 92.5% of individuals (and likely much more) are, essentially, incapable of developing MS, regardless of their specific environmental-exposures. Nevertheless, the genetics is complex and the contribution of any specific gene to MS-susceptibility seems to be quite modest. Thus, even for the DRB1*1501 allele (the strongest known MS-susceptibility marker), most carriers are not in the genetically-susceptible group. Moreover, 45-50% of individuals with MS lack this allele entirely and some of the haplotypes that carry this allele don't also confer any disease-risk. Finally, because the prevalence of genetic-susceptibility seems to be so similar throughout North America and Europe, and despite the crucial importance of a person's genetic make-up to disease pathogenesis, it is the environmental-factors, which largely responsible for the observed regional variations in disease-characteristics. Thus, despite MS being more common in women, men are more likely to be genetically-susceptible. This apparent paradox seems to relate to the fact that women are much more responsive than men to the recent changes in environmental-exposure (whatever these have been). These gender-differences may help to explain changes in the sex-ratio and the increasing disease-prevalence, which have both been observed recently. The potential importance of these conclusions regarding the role of environment in MS-pathogenesis is that they open the door to the possibility of pursuing strategies for primary primary disease prevention in the future.
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epstein Barr; cause; disease course; environment; gender; genetics; infection; natural history; obesity; pathogenesis; pregnancy; smoking; stress; susceptibility; trauma; virus; vitamin D

Mesh:

Year:  2016        PMID: 27637959     DOI: 10.1016/B978-0-12-802973-2.00011-2

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  11 in total

1.  Intravenous immunoglobulin treatment in multiple sclerosis: A prospective, rater-blinded analysis of relapse rates during pregnancy and the postnatal period.

Authors:  Alexander Winkelmann; Paulus Stefan Rommer; Michael Hecker; Uwe Klaus Zettl
Journal:  CNS Neurosci Ther       Date:  2018-06-01       Impact factor: 5.243

Review 2.  Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases.

Authors:  Xandy Melissa Rodríguez Mesa; Andrés Felipe Moreno Vergara; Leonardo Andrés Contreras Bolaños; Natalia Guevara Moriones; Antonio Luis Mejía Piñeros; Sandra Paola Santander González
Journal:  Cannabis Cannabinoid Res       Date:  2021-05-24

3.  The nature of genetic and environmental susceptibility to multiple sclerosis.

Authors:  Douglas S Goodin; Pouya Khankhanian; Pierre-Antoine Gourraud; Nicolas Vince
Journal:  PLoS One       Date:  2021-03-22       Impact factor: 3.240

Review 4.  Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis.

Authors:  Michael Hecker; Jan Bühring; Brit Fitzner; Paulus Stefan Rommer; Uwe Klaus Zettl
Journal:  Biomolecules       Date:  2021-10-13

5.  Genetic susceptibility to multiple sclerosis: interactions between conserved extended haplotypes of the MHC and other susceptibility regions.

Authors:  D S Goodin; P Khankhanian; P A Gourraud; N Vince
Journal:  BMC Med Genomics       Date:  2021-07-10       Impact factor: 3.063

Review 6.  Systematic Review of Studies on Telomere Length in Patients with Multiple Sclerosis.

Authors:  Jan Bühring; Michael Hecker; Brit Fitzner; Uwe Klaus Zettl
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

7.  Comparing the Effectiveness of Computer-Based, Manual-based, and Combined Cognitive Rehabilitation on Cognitive Functions in Relapsing-Remitting Multiple Sclerosis Patients.

Authors:  Mehri Rahmani; Isaac Rahimian Boogar; Siavash Talepasand; Mostafa Nokani
Journal:  Basic Clin Neurosci       Date:  2020-01-01

Review 8.  Gender medicine: Lessons from COVID-19 and other medical conditions for designing health policy.

Authors:  Yossy Machluf; Yoram Chaiter; Orna Tal
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

9.  Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course.

Authors:  Bardia Nourbakhsh; Pavan Bhargava; Helen Tremlett; Janace Hart; Jennifer Graves; Emmanuelle Waubant
Journal:  Ann Clin Transl Neurol       Date:  2018-09-27       Impact factor: 4.511

10.  Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States.

Authors:  David M Kern; M Soledad Cepeda
Journal:  BMC Neurol       Date:  2020-08-11       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.